色素-话题@MedSci

#色素#

654篇内容 | 6199人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1680560, encodeId=926e1680560a4, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=CLIN CANCER RES：抗CTLA4治疗对过继TIL疗法治疗转移性黑色素瘤患者的影响, objectType=article, longId=149295, objectId=4fc11492954f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fc11492954f, replyNumber=0, likeNumber=85, createdTime=2019-04-15, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fc11492954f, moduleTitle=CLIN CANCER RES：抗CTLA4治疗对过继TIL疗法治疗转移性黑色素瘤患者的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fc11492954f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680575, encodeId=be2a16805e5bd, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NCCN临床实践指南：皮肤黑色素瘤（2019.V1）, objectType=article, longId=153291, objectId=7aec15329163, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7aec15329163, replyNumber=0, likeNumber=14, createdTime=2019-06-27, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7aec15329163, moduleTitle=NCCN临床实践指南：皮肤黑色素瘤（2019.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7aec15329163)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680539, encodeId=59fd1680539c4, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=CLIN CANCER RES：CD103+肿瘤定植CD8+T细胞与黑色素瘤患者接受抗PD-1治疗预后改善有关, objectType=article, longId=142284, objectId=ca2e14228497, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca2e14228497, replyNumber=0, likeNumber=69, createdTime=2018-08-31, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca2e14228497, moduleTitle=CLIN CANCER RES：CD103+肿瘤定植CD8+T细胞与黑色素瘤患者接受抗PD-1治疗预后改善有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca2e14228497)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680574, encodeId=5d6716805e40e, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JCO：Pembrolizumab治疗具有脑转移的黑色素瘤：II期临床, objectType=article, longId=153201, objectId=ee2f15320164, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee2f15320164, replyNumber=0, likeNumber=54, createdTime=2019-01-25, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee2f15320164, moduleTitle=JCO：Pembrolizumab治疗具有脑转移的黑色素瘤：II期临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee2f15320164)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680484, encodeId=63a31680484b7, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=EUR J Cancer：使用PD-1抗体 pembrolizumab治疗转移性黑色素瘤及非黑素瘤皮肤癌中的着色性干皮症, objectType=article, longId=124993, objectId=4f6412499324, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f6412499324, replyNumber=0, likeNumber=91, createdTime=2018-03-08, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f6412499324, moduleTitle=EUR J Cancer：使用PD-1抗体 pembrolizumab治疗转移性黑色素瘤及非黑素瘤皮肤癌中的着色性干皮症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f6412499324)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680537, encodeId=e196168053e92, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=【盘点】黑色素瘤近期重要研究进展一览, objectType=article, longId=142087, objectId=0d7314208e98, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d7314208e98, replyNumber=0, likeNumber=57, createdTime=2019-04-22, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d7314208e98, moduleTitle=【盘点】黑色素瘤近期重要研究进展一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d7314208e98)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680552, encodeId=d0b616805527c, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Omid Hamid教授：黑色素瘤免疫治疗一线应用疗效更佳, objectType=article, longId=147831, objectId=03e014e831a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03e014e831a0, replyNumber=0, likeNumber=74, createdTime=2019-06-28, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03e014e831a0, moduleTitle=Omid Hamid教授：黑色素瘤免疫治疗一线应用疗效更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03e014e831a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680497, encodeId=d781168049e2f, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Autophagy：如何提高黑色素瘤患者存活率？, objectType=article, longId=128208, objectId=eb091282087c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb091282087c, replyNumber=0, likeNumber=75, createdTime=2018-07-03, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb091282087c, moduleTitle=Autophagy：如何提高黑色素瘤患者存活率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb091282087c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680515, encodeId=f559168051574, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Sci Transl Med：视网膜色素上皮细胞移植有望治疗干性年龄相关性黄斑变性, objectType=article, longId=134652, objectId=7d0a134652c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d0a134652c0, replyNumber=0, likeNumber=81, createdTime=2018-09-02, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d0a134652c0, moduleTitle=Sci Transl Med：视网膜色素上皮细胞移植有望治疗干性年龄相关性黄斑变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d0a134652c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680472, encodeId=7ee916804e25f, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=全球用于治疗BRAFV600突变阳性的无法手术切除或转移性黑色素瘤的靶向新药佐博伏® 中国上市 CFDA审评概述, objectType=article, longId=122007, objectId=8d8a12200e1b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d8a12200e1b, replyNumber=0, likeNumber=69, createdTime=2018-05-26, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d8a12200e1b, moduleTitle=全球用于治疗BRAFV600突变阳性的无法手术切除或转移性黑色素瘤的靶向新药佐博伏® 中国上市 CFDA审评概述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d8a12200e1b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680534, encodeId=d787168053447, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=2018 SITC共识声明：皮肤黑色素瘤的免疫治疗（更新版）, objectType=article, longId=139957, objectId=641513995e4c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=641513995e4c, replyNumber=0, likeNumber=14, createdTime=2019-02-12, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=641513995e4c, moduleTitle=2018 SITC共识声明：皮肤黑色素瘤的免疫治疗（更新版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=641513995e4c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680571, encodeId=63c116805e19e, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet oncol：Nivolumab联合伊匹单抗或单独用于治疗晚期黑色素瘤可获得持久稳定的疗效, objectType=article, longId=152046, objectId=95d615204647, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95d615204647, replyNumber=0, likeNumber=73, createdTime=2019-07-09, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95d615204647, moduleTitle=Lancet oncol：Nivolumab联合伊匹单抗或单独用于治疗晚期黑色素瘤可获得持久稳定的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95d615204647)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680488, encodeId=13711680488e2, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Sci Transl Med：重磅！人多能干细胞来源的视网膜上皮细胞有望治愈视网膜色素变性！, objectType=article, longId=125587, objectId=cbb812558eec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbb812558eec, replyNumber=0, likeNumber=82, createdTime=2018-09-11, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbb812558eec, moduleTitle=Sci Transl Med：重磅！人多能干细胞来源的视网膜上皮细胞有望治愈视网膜色素变性！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbb812558eec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680542, encodeId=b4dd16805421e, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Autophagy：体内体外实验证实吞噬体成熟受阻是视网膜色素上皮病理变化的基础, objectType=article, longId=145055, objectId=6c26145055c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c26145055c8, replyNumber=0, likeNumber=58, createdTime=2019-02-22, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c26145055c8, moduleTitle=Autophagy：体内体外实验证实吞噬体成熟受阻是视网膜色素上皮病理变化的基础, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c26145055c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680487, encodeId=4e51168048e94, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=【盘点】黑色素瘤2017重要研究进展汇总, objectType=article, longId=125231, objectId=e3a3125231db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3a3125231db, replyNumber=0, likeNumber=51, createdTime=2018-07-22, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3a3125231db, moduleTitle=【盘点】黑色素瘤2017重要研究进展汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3a3125231db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680573, encodeId=89f116805e3f5, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JCO：Dabrafenib联合Trametinib对BRAFV600突变Ⅲ期黑色素瘤患者无复发生存有益, objectType=article, longId=152422, objectId=77eb15242261, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77eb15242261, replyNumber=0, likeNumber=109, createdTime=2019-09-26, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77eb15242261, moduleTitle=JCO：Dabrafenib联合Trametinib对BRAFV600突变Ⅲ期黑色素瘤患者无复发生存有益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77eb15242261)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680496, encodeId=68e5168049640, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Mol Cell：厦大陈航姿、吴乔团队揭示脂肪酸氧化在黑色素瘤转移中的重要作用, objectType=article, longId=127811, objectId=f87612e8114d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f87612e8114d, replyNumber=0, likeNumber=85, createdTime=2018-07-21, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f87612e8114d, moduleTitle=Mol Cell：厦大陈航姿、吴乔团队揭示脂肪酸氧化在黑色素瘤转移中的重要作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f87612e8114d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680535, encodeId=a7bb168053555, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet oncol：MAGE-A3免疫疗法用于黑色素瘤无治疗效果！, objectType=article, longId=140798, objectId=15ed140e98fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15ed140e98fe, replyNumber=0, likeNumber=75, createdTime=2018-08-08, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15ed140e98fe, moduleTitle=Lancet oncol：MAGE-A3免疫疗法用于黑色素瘤无治疗效果！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15ed140e98fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680493, encodeId=25f316804930f, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=中国黑色素瘤规范化病理诊断专家共识（2017年版）, objectType=article, longId=127035, objectId=00ba12e0350e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00ba12e0350e, replyNumber=0, likeNumber=11, createdTime=2018-02-05, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00ba12e0350e, moduleTitle=中国黑色素瘤规范化病理诊断专家共识（2017年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00ba12e0350e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680567, encodeId=60b7168056e85, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Biomarkers：染色体3是近距离放射治疗葡萄膜黑色素瘤的有效预后标志物, objectType=article, longId=151371, objectId=877a1513e1a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=877a1513e1a3, replyNumber=0, likeNumber=92, createdTime=2019-07-28, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=877a1513e1a3, moduleTitle=Biomarkers：染色体3是近距离放射治疗葡萄膜黑色素瘤的有效预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=877a1513e1a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

色素

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#色素#

CLIN CANCER RES：抗CTLA4治疗对过继TIL疗法治疗转移性黑色素瘤患者的影响

2019-04-15

sunylz (审核中...)

前往app查看评论内容

#色素#

NCCN临床实践指南：皮肤黑色素瘤（2019.V1）

2019-06-27

sunylz (审核中...)

前往app查看评论内容

#色素#

CLIN CANCER RES：CD103+肿瘤定植CD8+T细胞与黑色素瘤患者接受抗PD-1治疗预后改善有关

2018-08-31

sunylz (审核中...)

前往app查看评论内容

#色素#

JCO：Pembrolizumab治疗具有脑转移的黑色素瘤：II期临床

2019-01-25

sunylz (审核中...)

前往app查看评论内容

#色素#

EUR J Cancer：使用PD-1抗体 pembrolizumab治疗转移性黑色素瘤及非黑素瘤皮肤癌中的着色性干皮症

2018-03-08

sunylz (审核中...)

前往app查看评论内容

#色素#

【盘点】黑色素瘤近期重要研究进展一览

2019-04-22

sunylz (审核中...)

前往app查看评论内容

#色素#

Omid Hamid教授：黑色素瘤免疫治疗一线应用疗效更佳

2019-06-28

sunylz (审核中...)

前往app查看评论内容

#色素#

Autophagy：如何提高黑色素瘤患者存活率？

2018-07-03

sunylz (审核中...)

前往app查看评论内容

#色素#

Sci Transl Med：视网膜色素上皮细胞移植有望治疗干性年龄相关性黄斑变性

2018-09-02

sunylz (审核中...)

前往app查看评论内容

#色素#

全球用于治疗BRAFV600突变阳性的无法手术切除或转移性黑色素瘤的靶向新药佐博伏® 中国上市 CFDA审评概述

2018-05-26

sunylz (审核中...)

前往app查看评论内容

#色素#

2018 SITC共识声明：皮肤黑色素瘤的免疫治疗（更新版）

2019-02-12

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet oncol：Nivolumab联合伊匹单抗或单独用于治疗晚期黑色素瘤可获得持久稳定的疗效

2019-07-09

sunylz (审核中...)

前往app查看评论内容

#色素#

Sci Transl Med：重磅！人多能干细胞来源的视网膜上皮细胞有望治愈视网膜色素变性！

2018-09-11

sunylz (审核中...)

前往app查看评论内容

#色素#

Autophagy：体内体外实验证实吞噬体成熟受阻是视网膜色素上皮病理变化的基础

2019-02-22

sunylz (审核中...)

前往app查看评论内容

#色素#

【盘点】黑色素瘤2017重要研究进展汇总

2018-07-22

sunylz (审核中...)

前往app查看评论内容

#色素#

JCO：Dabrafenib联合Trametinib对BRAFV600突变Ⅲ期黑色素瘤患者无复发生存有益

2019-09-26

sunylz (审核中...)

前往app查看评论内容

#色素#

Mol Cell：厦大陈航姿、吴乔团队揭示脂肪酸氧化在黑色素瘤转移中的重要作用

2018-07-21

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet oncol：MAGE-A3免疫疗法用于黑色素瘤无治疗效果！

2018-08-08

sunylz (审核中...)

前往app查看评论内容

#色素#

中国黑色素瘤规范化病理诊断专家共识（2017年版）

2018-02-05

sunylz (审核中...)

前往app查看评论内容

#色素#

Biomarkers：染色体3是近距离放射治疗葡萄膜黑色素瘤的有效预后标志物

2019-07-28

科室
- - 订阅+
  - 更多科室
工具
服务